Nadeem Muhammad, Khan Rijma, Shah Nausheen, Bangash Ishrat Rehman, Abbasi Bilal Haider, Hano Christophe, Liu Chunzhao, Ullah Sana, Hashmi Syed Salman, Nadhman Akhtar, Celli Jonathan
Department of Biotechnology, Institute of Integrative Biosciences, CECOS University, Peshawar 25100, Pakistan.
Department of Biotechnology, Quaid-i-Azam University, Islamabad 45320, Pakistan.
Nanomaterials (Basel). 2021 Dec 31;12(1):130. doi: 10.3390/nano12010130.
Nanotechnology is a booming avenue in science and has a multitude of applications in health, agriculture, and industry. It exploits materials' size at nanoscale (1-100 nm) known as nanoparticles (NPs). These nanoscale constituents are made via chemical, physical, and biological methods; however, the biological approach offers multiple benefits over the other counterparts. This method utilizes various biological resources for synthesis (microbes, plants, and others), which act as a reducing and capping agent. Among these sources, microbes provide an excellent platform for synthesis and have been recently exploited in the synthesis of various metallic NPs, in particular iron. Owing to their biocompatible nature, superparamagnetic properties, small size efficient, permeability, and absorption, they have become an integral part of biomedical research. This review focuses on microbial synthesis of iron oxide nanoparticles using various species of bacteria, fungi, and yeast. Possible applications and challenges that need to be addressed have also been discussed in the review; in particular, their antimicrobial and anticancer potentials are discussed in detail along with possible mechanisms. Moreover, some other possible biomedical applications are also highlighted. Although iron oxide nanoparticles have revolutionized biomedical research, issues such as cytotoxicity and biodegradability are still a major bottleneck in the commercialization of these nanoparticle-based products. Addressing these issues should be the topmost priority so that the biomedical industry can reap maximum benefit from iron oxide nanoparticle-based products.
纳米技术是科学领域中一条蓬勃发展的途径,在健康、农业和工业等方面有众多应用。它利用纳米尺度(1-100纳米)的材料,即所谓的纳米颗粒(NPs)。这些纳米级成分通过化学、物理和生物方法制备;然而,生物方法相对于其他方法具有多种优势。这种方法利用各种生物资源进行合成(微生物、植物等),这些生物资源充当还原剂和封端剂。在这些资源中,微生物为合成提供了一个极好的平台,最近已被用于各种金属纳米颗粒的合成,特别是铁纳米颗粒。由于其生物相容性、超顺磁性、小尺寸高效性、渗透性和吸收性,它们已成为生物医学研究不可或缺的一部分。本综述重点关注利用各种细菌、真菌和酵母物种进行氧化铁纳米颗粒的微生物合成。综述中还讨论了需要解决的可能应用和挑战;特别是详细讨论了它们的抗菌和抗癌潜力以及可能的机制。此外,还强调了一些其他可能的生物医学应用。尽管氧化铁纳米颗粒彻底改变了生物医学研究,但细胞毒性和生物降解性等问题仍然是这些基于纳米颗粒的产品商业化的主要瓶颈。解决这些问题应是最首要的任务,以便生物医学行业能够从基于氧化铁纳米颗粒的产品中获得最大利益。